Navigation Links
Verenium Announces Changes in Senior Management
Date:2/25/2011

SAN DIEGO, Feb. 25, 2011 /PRNewswire/ -- Verenium Corporation (Nasdaq: VRNM), a pioneer in the development and commercialization of high-performance industrial enzyme solutions, today announced a series of changes within its senior management team to take effect March 31:

  • Carlos Riva, currently Director, President and Chief Executive Officer, will be retiring from his position at the Company.  He will continue to be available to the Company as a consultant for a period of time.
  • James Levine, currently Executive Vice President and Chief Financial Officer, will be promoted to President and Chief Executive Officer, succeeding Carlos Riva.  He will also be elected to the Company's Board of Directors.
  • Jeffrey Black, currently Senior Vice President and Chief Accounting Officer, will be promoted to Chief Financial Officer.  He will continue to report to Levine.
  • Janet Roemer will continue as Chief Operating Officer and will report to Levine.

  • "This is an exciting time for Verenium and I am very pleased to have the opportunity to continue to partner with Janet, Jeff and the rest of our team as we focus on realizing Verenium's vision of building the next leading industrial enzymes company," said James Levine, President and Chief Executive Officer Designate of Verenium.  "On behalf of the Company and our Board of Directors, I'd also like to recognize the many contributions Carlos made in his time here and wish him well with his future plans."

    About VereniumVerenium, an industrial biotechnology company, is a global leader in developing high-performance enzymes.  Verenium's tailored enzymes are environmentally friendly, making products and processes greener and more cost-effective for industries, including the global food and fuel markets.  Read more at www.verenium.com'/>"/>

    SOURCE Verenium Corporation
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2 3

    Related medicine technology :

    1. Verenium Announces 2010 Business Update and Outlook for 2011
    2. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
    3. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
    4. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
    5. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
    6. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
    7. Phosphagenics Announces Positive Phase 1b Transdermal Insulin Clinical Trial Results
    8. Xenomics Announces Implementation of its First Diagnostic Test for Acute Myeloid Leukemia Into Clinical Practice
    9. Emisphere Technologies, Inc. Announces 2007 Second Quarter Financial Results
    10. Amicus Therapeutics Announces Second Quarter 2007 Financial Results
    11. Genta Incorporated Announces Second Quarter 2007 Financial Results and Corporate Highlights
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:11/22/2014)...   Long Beach dentist , Dr. Rassouli, is now ... standard in tooth replacement because they offer the closest match ... restore and preserve smiles and improve overall dental health. Dr. ... or as a part of a smile makeover or full ... a smile. The loss of a tooth can ...
    (Date:11/22/2014)... 21, 2014 Many power shifts are ... influence of patients in the biopharmaceutical market is ... more than ever, understanding how to effectively acquire, ... is essential. According to recent ... companies spent about two-thirds of their patient-focused dollars ...
    (Date:11/21/2014)... , Nov. 21, 2014 In September ... Performance Scrubs carried out a new product development plan ... very first "limited edition" lab coat , aptly ... professors of surgery in the world. The new women,s ... unisex predecessors, with a sleek envelope collar, vertical princess ...
    Breaking Medicine Technology:Long Beach Dentist, Dr. Rassouli, is Now Offering Dental Implants 2New Report Details Importance of Adopting a "Patient Journey" Framework in Marketing 2Medelita Introduces Medical Industry's First Limited Edition Women's Designer Lab Coat 2
    ... Sept. 19 A new topical lotion that,penetrates ... serious skin,infections, but without being systemically absorbed, has ... patients with onychomycosis, or,toenail fungus, a new study ... clinical trial are important to the fields of,dermatology ...
    ... Targanta,s Novel Drug Discovery Platform, CHICAGO, Sept. ... from two studies highlighting the in vitro,activity and ... osteomyelitis,models. Results are being presented today at the ... (ICAAC) taking place in,Chicago, IL and represent the ...
    Cached Medicine Technology:New Topical Therapy Safely Treats Serious Skin Infections Without Systemic Side Effects 2New Topical Therapy Safely Treats Serious Skin Infections Without Systemic Side Effects 3Targanta Presents First Data Demonstrating In Vitro Activity and In Vivo Efficacy of Prodrugs in Osteomyelitis Models 2Targanta Presents First Data Demonstrating In Vitro Activity and In Vivo Efficacy of Prodrugs in Osteomyelitis Models 3
    (Date:11/22/2014)... (PRWEB) November 22, 2014 Hastings and ... decades of experience announces providing clients with the option ... firm offers clients a flexible, intuitive and easy to ... with having access to Google + allows clients to ... to make a more informed decision when retaining an ...
    (Date:11/22/2014)... FL (PRWEB) November 22, 2014 ... Innovations are pleased to announce that Ashley Lombardo ... Thanksgiving #PayItForward contest. , Ms. Lombardo entered friend ... Kitchen Innovations. She wrote of how her friend is ... daughters as a single mom. Despite medical bills piling ...
    (Date:11/22/2014)... Boulder, CO (PRWEB) November 22, 2014 ... on growth equity investments in the consumer brand ... LLC. The investment will be used to help ... new product pipeline rollout, particularly its proprietary apparel ... Suslow will join BackJoy’s Board of Directors. , ...
    (Date:11/22/2014)... Aliso Viejo, California (PRWEB) November 22, 2014 ... have announced a new plugin entitled FCPX 3D Model bringing ... , “FCPX 3D Model allows users to add obj files ... of Pixel Film Studios. “Blurring the line between professional and ... FCPX3D Model from Pixel Film Studios allows Final Cut Pro ...
    (Date:11/22/2014)... Wright & Schulte LLC reports that six ... been scheduled between October 2016 and April 2017 in ... District Judge Matthew F. Kennelly, who is overseeing the ... on November 6, 2014 that outlined the trial schedule ... and other activities in preparation for the bellwether jury ...
    Breaking Medicine News(10 mins):Health News:Hastings and Hastings Announces Providing Clients with the Option of Leaving an Online Review Using Google + 2Health News:Hastings and Hastings Announces Providing Clients with the Option of Leaving an Online Review Using Google + 3Health News:Forbes Living TV Announces Winner of Thanksgiving #PayItForward Contest 2Health News:Sandbridge Capital Acquires a Minority Stake in BackJoy 2Health News:Sandbridge Capital Acquires a Minority Stake in BackJoy 3Health News:Pixel Film Studios released FCPX 3D Model plugin Exclusively for Final Cut Pro X 2Health News:First Bellwether Trials Scheduled In AndroGel Side-Effects Lawsuits Reports Wright & Schulte LLC 2Health News:First Bellwether Trials Scheduled In AndroGel Side-Effects Lawsuits Reports Wright & Schulte LLC 3Health News:First Bellwether Trials Scheduled In AndroGel Side-Effects Lawsuits Reports Wright & Schulte LLC 4
    ... Assam and Tripura have warned people against eating fish// ... saying the long time taken in transit rendered the ... ,The warning follows a report by the ... husks gets contaminated during the eight to 10 day ...
    ... Medical Journal report says that staff shortages in radiotherapy units ... and thus reducing their chances of surviving the condition. ... those in most developed countries and indeed many poorer countries," ... BMJ report. "Unfortunately the here and now of this is ...
    ... Ontario Government to launch a programme to ensure provision ... assault, who might have been exposed to the HIV/AIDS ... ($1,200) has resulted in a limited availability of this ... ,Very little effort is being done to promote ...
    ... the Health Minister of the Indian State of Bihar has announced ... introduced// in the state. An annual premium of Rs 250 will ... This will serve to provide the family with free health services ... the poverty line will receive the benefits without having to pay ...
    ... therapy is being provided to people who wish to give ... are over the age of 18 years// will benefit from ... Treatment for Ontario Patients (STOP) Study, which will also provide ... to which quitting method is more effective, according to Center ...
    ... transfer technology to generic drug manufacturers in the ... versions of the HIV drug saquinavir. ... Roche has announced further expansion of its current ... Developed Countries by providing local manufacturers with the ...
    Cached Medicine News:Health News:Reach Of The Morning-After Pill Treatment Inadequate Among Sexual Assault Victims 2Health News:Roche offers HIV drug expertise to poor nations 2
    Replacement bulb for Vibratome light system....
    Injector blades come ten to an injector and allow for the easy replacement of Vibratome cutting blades....
    Vibratome Specimen Adhesive is a special formulation developed by a major adhesive manufacturer for applications such as tissue mounting. The advantage of this adhesive is that it has a strong holdi...
    ... The Deluxe specimen bath mounts inside the ... bath allows for the separation of buffer and ... The bath can be sterilized and has round ... mounting specimens. The disks and bath surface ...
    Medicine Products: